High accuracy model for HBsAg loss based on longitudinal trajectories of serum qHBsAg throughout long-term antiviral therapy
Rong Fan(Kunming Institute of Botany), Jinlin Hou(Southern Medical University), Yanyan Yu(Nanchang University), Jian Sun(Nanfang Hospital), Nikolai V. Naoumov(Novartis (Switzerland)), Huiying Rao(Peking University), Xiaoguang Dou(China Medical University), Xieer Liang(Nanfang Hospital), Qing Xie(Ruijin Hospital), Hongbo Gao(Houston Methodist), Yali Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Yongfeng Yang(Capital Medical University), Qi Xia(Peking University), Yang Song(Nanjing Medical University), Aimin Sun(Zhengzhou University), Hong Ma(Beijing Friendship Hospital), Xueru Yin(Key Laboratory of Guangdong Province), Yongfang Jiang(Central South University), Siru Zhao(Nanfang Hospital), Jia Shang(European Foundation for the Study of Chronic Liver Failure), Jianping Xie(Central South University), Junqi Niu(Jilin University)
Cited by 22
Related Papers
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
|The Lancet. Gastroenterology & hepatology|2019|539
aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis
|Journal of Hepatology|2020|346
Guideline of Prevention and Treatment for Chronic Hepatitis B (2015 Update)
|Journal of Clinical and Translational Hepatology|2017|277
VV116 versus Nirmatrelvir–Ritonavir for Oral Treatment of Covid-19
|New England Journal of Medicine|2022|227